title: The transition from acute to chronic pain: understanding how different biological systems interact.
abstract: OBJECTIVE
  Although pain is an adaptive sensory experience necessary to prevent further bodily harm, the transition from acute to chronic pain is not adaptive and results in the development of a chronic clinical condition. How this transition occurs has been the focus of intense study for some time. The focus of the current review is on changes in neuronal plasticity as well as the role of immune cells and glia in the development of chronic pain from acute tissue injury and pain.
  
  
  RESULTS
  Our understanding of the complex pathways that mediate the transition from acute to chronic pain continues to increase. Work in this area has already revealed the complex interactions between the nervous and immune system that result in both peripheral and central sensitization, essential components to the development of chronic pain. Taken together, a thorough characterization of the cellular mechanisms that generate chronic pain states is essential for the development of new therapies and treatments. Basic research leading to the development of new therapeutic targets is promising with the development of chloride extrusion enhancers. It is hoped that one day they will provide relief to patients with chronic pain.
  
  
  CONCLUSIONS
  A better understanding of how chronic pain develops at a mechanistic level can aid clinicians in treating their patients by showing how the underlying biology of chronic pain contributes to the clinical manifestations of pain. A thorough understanding of how chronic pain develops may also help identify new targets for future analgesic drugs.
authors.affiliation: Centre for Neuroscience, University of Alberta, Edmonton, AB, Canada.
authors.forename: Katherine A
authors.initials: KA
authors.lastname: Mifflin
authors.forename: Bradley J
authors.initials: BJ
authors.lastname: Kerr
mesh_terms: D059787:Acute Pain / Q000188:drug therapy / Q000503:physiopathology*; D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D059350:Chronic Pain / Q000188:drug therapy / Q000503:physiopathology*; D015195:Drug Design; D006801:Humans; D007107:Immune System / Q000502:physiology; D058990:Molecular Targeted Therapy; D009457:Neuroglia / Q000502:physiology; D009473:Neuronal Plasticity / Q000502:physiology
chemical_list: D000700:Analgesics